multiple myeloma

1. Observation on the efficacy of donor leukocyte infusion in acute chronic leukemia and multiple myeloma
   供体白细胞输注治疗急慢性白血病和多发性骨髓瘤
2. Effectiveness and Safety of Thalidomide for Treating Multiple Myeloma in China: A Meta-analysis
   国内沙利度胺治疗多发性骨髓瘤疗效与安全性的Meta分析
3. The skull demonstrates the characteristic rounded "punched out" lesions of multiple myeloma.
   颅骨显示多发性骨髓瘤典型的圆形“打孔样”病损。
4. Advances on the c-maf Proto-oncogene in Multiple Myeloma
   原癌基因c-maf在多发性骨髓瘤中的研究进展
5. A Study on the Treatment of Multiple Myeloma with VAD Regimen
   VAD方案用于多发性骨髓瘤治疗的研究
6. Notch Signaling Pathway and Multiple Myeloma& Review
   Notch信号通路和多发性骨髓瘤
7. Expression of Pituitary Tumor Transforming Gene and C-myc Gene in Patients with Multiple Myeloma
   垂体瘤转化基因和C-myc基因在多发性骨髓瘤中表达的研究
8. Diagnostic value of multiparameter flow cytometry for Multiple Myeloma
   多参数流式细胞术在多发性骨髓瘤诊断中的价值
9. Studies on the Expression and Function of Annexin ⅱ in Multiple Myeloma and Other Neoplastic Hematologic Disorders
   AnnexinⅡ在多发性骨髓瘤及其他血液肿瘤中的表达及机制研究
10. The Cystic Fibrosis Foundation has revolutionized the way drugs for rare diseases are developed and the Multiple Myeloma Research Foundation has helped change the way that blood cancer is treated.
    囊性纤维化基金会（CysticFibrosisFoundation）使罕见疾病药物的开发方式发生了变革，多发性骨髓瘤研究基金会（MultipleMyelomaResearchFoundation）已经帮助医生改变了血癌的治疗方法。
11. Cancergrams: CT13 Clinical Evaluation and Treatment of Multiple Myeloma and Other Gammopathies.
    CT13多发性骨髓瘤和其他起因不明病临床评价和治疗。
12. The clinical study of thalidomide combining with chemotherapy in treating of multiple myeloma
    沙利度胺联合化疗治疗多发性骨髓瘤临床研究
13. The effects of Thalidomide-Combination chemotherapy on cytokine in patients with multiple myeloma
    沙利度胺联合VAD方案化疗对多发性骨髓瘤病人细胞因子影响
14. A Study of the Clinical Features of Multiple Myeloma with Acute Renal Failure
    多发性骨髓瘤并发急性肾衰竭临床特点研究
15. Clinical study on prognostic factors and life span of multiple myeloma
    多发性骨髓瘤预后因素和生存期评价的临床分析
16. Expressions and significance of IL-6 and TNF-α of the multiple myeloma bone marrow stromal cells
    多发性骨髓瘤骨髓基质细胞IL-6和TNF-α的表达及其临床意义
17. Tumor: such as multiple myeloma.
    肿瘤性：如多发性骨髓瘤。
18. Multiple myeloma ( MM) is an incurable clonal B-cell malignancy with terminally differentiated plasma cells.
    多发性骨髓病（MM）是一种浆细胞异常增生的难治愈的B细胞恶性肿瘤。
19. Expression of Midkine and Vascular Endothelial Growth Factor in Bone Marrow of Patients with Multiple Myeloma and Its Significance
    中期因子及血管内皮生长因子在多发性骨髓瘤患者骨髓中的表达及意义
20. Retrospective Analysis of 71 Cases of Multiple Myeloma
    71例初治多发性骨髓瘤的回顾性分析
21. Effects of different doses of thalidomide in treating multiple myeloma
    不同剂量沙利度胺对多发性骨髓瘤的疗效观察
22. Clinic and Imaging Diagnosis Study on Multiple Myeloma
    多发性骨髓瘤的临床与影像学诊断研究
23. BAG-1 and BCL-2 expression in tissues of multiple myeloma
    多发性骨髓瘤患者BAG-1和BCL-2在骨髓活检组织的表达
24. Anticancer activity of this agent has been reported in various malignant disorders, including multiple myeloma and myelodysplastic syndrome.
    它对多种肿瘤具有抗肿瘤活性，其中包括骨髓瘤和骨髓增生异常综合征。
25. Analysis of depression and anxiety in patients with multiple myeloma
    多发性骨髓瘤患者抑郁和焦虑情绪及其相关因素分析
26. Expression and Significance of Pokemon in Diffuse Large B-Cell Lymphoma and Multiple Myeloma
    Pokemon在弥漫性大B细胞淋巴瘤和多发性骨髓瘤中的表达和意义
27. Objective To compare the curative effect of T-VAD regimen and VAD regimen in the treatment of multiple myeloma.
    目的评价T-VAD（沙利度胺联合VAD方案）和VAD方案治疗多发性骨髓瘤的疗效。
28. This article was to study the effect of multiple myeloma cell lines conditioned media on the proliferation, migration and angiogenesis of human bone marrow endothelial cells ( HBMEC).
    探讨多发性骨髓瘤细胞系培养上清液对人骨髓来源内皮细胞系（HBMEC）的增殖、迁移及血管新生的作用。
29. At low power, the abnormal plasma cells of multiple myeloma fill the marrow.
    低倍镜显示多发性骨髓瘤异常浆细胞弥漫浸润骨髓。
30. To explore foreseeable nursing intervention in the treatment of elderly multiple myeloma combined with thoracic and lumber vertebrae fracture.
    探讨预见性护理干预在老年性多发性骨髓瘤合并胸腰椎骨折患者护理中的应用和效果。

noun

1. myeloma that develops in several places at the same time